Return to Sport Programming for Patients with Postural Orthostatic Tachycardia Syndrome

Overview

About this study

The purpose of this study is is to evaluate the feasibility and preliminary effectiveness of the proposed return to sport protocol for patients with Postural Orthostatic Tachycardia Syndrome (POTS). This study aims to lay the groundwork for future research by demonstrating that patients with POTS can return to sport with appropriate management.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of Postural Orthostatic Tachycardia Syndrome.
  • Patients between the ages of 13-18.
  • Current or former athlete, defined as an individual who has participated in organized sport and expresses a desire to return to organized sport.
  • Cleared by the managing physician to begin an intensive exercise program.

Exclusion Criteria:

  • Medically unfit to begin an intensive exercise program:
    • As determined by the inability to complete ADLs due to the severity of symptoms, and/or the inability to exercise > 3 days weekly due to the severity of symptoms.
  • Active and uncontrolled Mast Cell Activation Syndrome:
    • As diagnosed by referring physician
    • Current statement by WHO states diagnostic criteria includes 2 or greater symptoms for 2 or more different systems, chronic and aberrant reactivity to identifiable triggers, and symptoms cannot reasonably be accounted for by another illness.
  • Uncontrolled post-exertional malaise:
    • Screened using DePaul Symptom Questionnaire – Post Exertional Malaise (DSQ-PEM)
    • Scores greater than 2,2 (frequency and severity) classify as uncontrolled PEM

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/15/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Christopher Nagelli, Ph.D., M.S.

Open for enrollment

Contact information:

Emma Stetler P.T., D.P.T.

(612) 313-0520

Kelly.Emma@mayo.edu

Minneapolis, Minn.

Mayo Clinic principal investigator

Christopher Nagelli, Ph.D., M.S.

Open for enrollment

Contact information:

Emma Stetler P.T., D.P.T.

(612) 313-0520

Kelly.Emma@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20581167

Mayo Clinic Footer